Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Saints Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
Saints Capital

Saints Capital

Operating

Saints Capital: A global venture capital firm based in San Francisco and London.

Location
San Francisco, CA, US
Founded
2000
Firm
Compare
Portfolio
Employees
News
Website

Investments

Xage Security
Xage Security

Total Raised

$81.2M

Rounds

3

Series B$60.1MNovember 2023
Direct Flow Medical
Direct Flow Medical
Acquired

Total Raised

$200.8M

Rounds

8

Series C$31MApril 2016
Actelis Networks
Actelis Networks
Public

Total Raised

$138.3M

Rounds

14

Series Unknown$2MFebruary 2016
Debt FinancingMarch 2014
Series Unknown$10MSeptember 2009
Gilt Groupe
Gilt Groupe

Total Raised

$286M

Rounds

7

Series F$50MFebruary 2015
Medvantx
Medvantx
Series D

Total Raised

$27.6M

Rounds

4

Series DDecember 2014
VisionCare Ophthalmic Technologies
VisionCare Ophthalmic Technologies
Acquired

Total Raised

$95.2M

Rounds

8

Series UnknownDecember 2014
Series E$31MJanuary 2011
Circadence
Circadence

Total Raised

$30.2M

Rounds

4

Debt FinancingJuly 2014
Arcadia Biosciences
Arcadia Biosciences
Public

Total Raised

$175.8M

Rounds

13

Series D$33MMay 2014
Private Equity$15MOctober 2008
Transonic Combustion
Transonic Combustion

Total Raised

$44M

Rounds

5

Debt FinancingMarch 2014
Series D$32MNovember 2012
NComputing
NComputing

Total Raised

$57.8M

Rounds

6

Debt FinancingFebruary 2014
Cellomics Technology
Cellomics Technology

Total Raised

$150k

Rounds

1

Seed$150kApril 2012
Solace Therapeutics
Solace Therapeutics

Total Raised

$36M

Rounds

5

Series Unknown$7MMarch 2012
Capella
Capella

Total Raised

$97.5M

Rounds

9

Series Unknown$20MApril 2011
Laureate Pharma
Laureate Pharma
Acquired

Total Raised

$20M

Rounds

1

Debt Financing$20MOctober 2010
Serious Energy
Serious Energy

Total Raised

$135.1M

Rounds

5

Series D$19.8MJune 2010
Seven Networks
Seven Networks

Total Raised

$126M

Rounds

5

Series Unknown$42MDecember 2006
Novera Optics
Novera Optics

Total Raised

$90.4M

Rounds

3

Series Unknown$7.4MMarch 2006